NCT06660056View on ClinicalTrials.gov

A Phase I Clinical Study of Intratumoral Injection GC001 in Patient With Recurrent or Progressive Gliomas

PHASE1RecruitingINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

October 8, 2024

Primary Completion Date

February 8, 2026

Study Completion Date

August 8, 2026

Conditions
High-grade Gliomas
Interventions
BIOLOGICAL

A Phase I Clinical Study of Intratumoral Injection Oncolytic Vaccinia Virus GC001 in Patient With Recurrent or Progressive Gliomas of the Brain

Use of Ommaya capsules

Trial Locations (1)

100000

RECRUITING

Beijing Tiantan Hospital,Capital Medical University, Beijing

All Listed Sponsors
lead

GONGCHU Biotechnology Co., Ltd

OTHER